Familial PAS+ E. coli + CD48/SLAM risk haplotype GC closely resembles very early onset, primary immunodeficiency related IBD and may serve to inform understanding of the etiopathogenesis and treatment of microbially driven intestinal inflammation across species. This evidence concerns the gene SLAMF1 and inflammatory bowel disease.